1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2018-2028

Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2018-2028

  • July 2018
  • 223 pages
  • ID: 5574228
  • Format: PDF
  • By Visiongain


Table of Contents

Retinal Disorder Drugs, Allergic, Inflammatory & Infective Drugs, Glaucoma Drugs, Dry Eye Drugs

The global ophthalmic drugs market was valued at $23bn in 2017. The market was dominated by the Retinal Disorder drug submarket which held 39.1% of the global ophthalmic drugs market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 223-page report you will receive 83 tables and 71 figures- all unavailable elsewhere.
The 223-page report provides clear detailed insight into the top ophthalmic drugs manufacturers. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope
- Global ophthalmic drugs market revenue forecasts from 2018-2028
- Global ophthalmic drugs market revenue orecasts from 2018-2028, by submarket:
- Retinal Disorder Drugs
- Allergic, Inflammatory & Infective Drugs
- Glaucoma Drugs
- Dry Eye Drugs
- Other Ophthalmic Drugs
- Revenue forecasts from 2018-2028 of the leading ophthalmic drugs:
- Alphagan
- Avastin
- Azopt
- Eylea
- Lucentis
- Lumigan & Ganfort
- Other Ophthalmic Drugs
- Restasis
- Vigamix
- Xalatan/Xalacom
- Our study discusses the selected leading companies that are the major players in the ophthalmic drugs industry:
- Acucela
- Akorn
- Alimera Sciences
- Allergan
- Amakem
- Bayer
- Chengdu Kanghong
- EyeGate Pharmaceuticals
- Gene Signal
- Icon Biosciences
- Neurotech
- Novartis
- Omeros
- Ophthotech
- Otsuka Pharmaceutical
- Pfizer
- pSivida Corp.
- Regeneron
- Roche
- Santen
- Senju
- Shire
- ThromboGenics
- Valeant
- Our report provides an overview, revenue forecast from 2018-2028 of the ophthalmic drugs segment, revenue forecast from 2018-2028 of the leading drugs, product pipeline and SWOT Analysis, for these companies:
- Akorn
- Alcon
- Allergan
- Bausch & Lomb
- Bayer
- Novartis
- Pfizer
- Regeneron
- Roche
- Santen
- Senju
- Valeant
- Our report provides these Qualitative Analysis:
- Drivers and Restraints of the Global Ophthalmic Drugs market
- SWOT Analysis of selected leading companies
- Porter’s Five Forces Analysis of the Global Ophthalmic Drugs Market

Please note: This report is accessed through a password system. Single user (non-printable) and departmental licenses expires after 12 month period.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Consumer Health in Egypt

Consumer Health in Egypt

  • $ 2650
  • October 2019

2019 saw further increases in value sales across most consumer health categories despite the strong unit price increases that were seen, the result of high inflation. Egypt is still recovering from the ...

Consumer Health in Italy

Consumer Health in Italy

  • $ 2650
  • October 2019

The focus on long-term health and prevention continues in Italy. Therefore, vitamins and dietary supplements and herbal/traditional products remain strong drivers of current value growth in 2019. The role ...

Consumer Health in Hong Kong, China

Consumer Health in Hong Kong, China

  • $ 2650
  • November 2019

Popularisation of various health concerns continues to fuel stable growth across all consumer health categories but most notably for over-the-counter (OTC) drugs. Given the lack of government health facilities, ...

Consumer Health in Spain $ 2650 October 2019

Consumer Health in Malaysia $ 2650 October 2019

Consumer Health in Thailand $ 2650 October 2019

Consumer Health in Denmark $ 2650 October 2019

Consumer Health in Israel $ 2650 October 2019

Consumer Health in South Korea $ 2650 October 2019

Consumer Health in Slovakia $ 2650 October 2019


Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on